In support of World Vitiligo Day, a new survey sheds light on emotional and social challenges faced by patients and their families.

(From left) Mr. Chan (pseudonym), a patient with vitiligo; Dr. Chan Yung, a specialist in dermatology; and Ms. Amy Wong, a ...

We play a lot of games in our lives. They've been around quite a while, after all. Since the 1980's, gaming has been a ...

Topical ruxolitinib cream shows promise as a treatment for inflammatory skin conditions, but lacks consistent data, indicating a need for further research into its use across various dermatologic ...

JAK inhibitors commonly induce acne in IBD patients, with upadacitinib posing the highest risk. Middle-aged adults and those ...

A keen rugby player who was left with brain damage and severe sight loss after he was knocked off his bike said he believed ...

Vitiligo Awareness Month and World Vitiligo Day aim to educate the public about the autoimmune skin condition's complex ...

Arcutis Biotherapeutics is a standout in biotech with FDA-approved ZORYVE and strong potential. See why we recommend a buy on ...

Now, the work presented at the 2025 annual EULAR congress in Barcelona adds two important pieces to the puzzle.

CDAI LDA (≤10) was achieved by 45% of 318 rosnilimab patients by Week 12, increasing to 69% (220 responders) across all doses by Week 14. As of the March 11 data cutoff, 83% of CDAI LDA responders at ...

In a recently published phase 2b extension study, adding narrow-band ultraviolet B (nbUVB) phototherapy to ritlecitinib, an oral Janus kinase (JAK) 3/tyrosine-protein kinase inhibitor, resulted in ...